15–16 Mar 2023
WHO Headquarters
Europe/Zurich timezone

This is the first investigators’ meeting corresponding to the Unitaid funded “Heat-stable carbetocin for the treatment of postpartum haemorrhage: a phase III, randomized, double-blind, active controlled, multicountry, multicentre, non-inferiority trial”  (REACH trial). This trial is part of a PPH portfolio funded by Unitaid. The trial is a component of a bigger project that HRP will conduct under Unitaid’s grant that aims at building an evidence ecosystem that will enable the right conditions for scale-up of HSC at global and country levels.

WHO Headquarters, Geneva, Switzerland
Registration for this event is currently open.